Skip to Main Content

We have a new app!

Take the Access library with you wherever you go—easy access to books, videos, images, podcasts, personalized features, and more.

Download the Access App here: iOS and Android


  • ACT: Activated clotting time Table 1A and B:

  • ACS: Acute coronary syndrome

  • Afib: Atrial fibrillation

  • Anesth.: Anesthesia

  • aPTT: Activated partial thromboplastin time

  • ASA: Acetylsalicylic acid

  • ATE: Arterial thromboembolism

  • BMS: Bare metal stent

  • COX: cyclooxygenase

  • CrCl: Creatinine clearance

  • CV: CHA2DS2-VASc

  • CVA: Cerebral vascular accident

  • CYP3A4: Cytochrome P450 3A4

  • DES: Drug eluting stent

  • DVT: Deep venous thrombosis

  • GP IIb-IIIa: glycoprotein IIb-IIIa

  • HB: HAS-BLED score

  • ICD: implantable cardioverter defibrillator

  • INR: International normalized ratio

  • IV: Intravenous

  • LMWH: Low molecular weight heparin

  • NOACs: New oral anticoagulants

  • OBR: Intra operative bleeding risk

  • Prim.: primary

  • PCI: Percutaneous coronary intervention

  • PE: Pulmonary embolism

  • P-gp: P-glycoprotein

  • PT: Prothrombin time

  • Prev.: prevention

  • PO: Per Os

  • RA: Regional anaesthesia

  • SC: Subcutaneous

  • Sec.: secondary

  • TER: Thrombo embolic risk

  • TIA: Transient ischemic attack

  • UFH: Unfractionated heparin

  • VKA: Vitamin K antagonist

  • VTE: Venous thromboembolism

Table 1–1A.Overview of antiplatelet agents and anticoagulants with clinically useful information about dosage and perioperative management of patients using this type of drug. The overview was composed from a perspective of medical practice in western europe (Belgium).

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.